BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.66
-0.20 (-2.54%)
At close: May 8, 2026, 4:00 PM EDT
7.60
-0.06 (-0.78%)
After-hours: May 8, 2026, 4:55 PM EDT
BridgeBio Oncology Therapeutics Employees
BridgeBio Oncology Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 30 or 48.39% compared to the previous year.
Employees
92
Change
30
Growth
48.39%
Revenue / Employee
n/a
Profits / Employee
-$1,457,000
Market Cap
613.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Sep 30, 2025 | 81 | 19 | 30.65% |
| Mar 31, 2025 | 62 | - | - |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| Arvinas | 246 |
| CorMedix | 191 |
| Cabaletta Bio | 156 |
| Prothena Corporation | 67 |
| AgomAb Therapeutics NV | 58 |
| Altimmune | 57 |
| Candel Therapeutics | 55 |
BBOT News
- 17 days ago - BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026 - GlobeNewsWire
- 17 days ago - BridgeBio Oncology appoints Pedro Beltran as CEO, Idan Elmelech as COO - TheFly
- 17 days ago - BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman - GlobeNewsWire
- 18 days ago - BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026 - GlobeNewsWire
- 19 days ago - BridgeBio Oncology announces FDA Fast Track Designation for BBO-11818 - TheFly
- 19 days ago - BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma - GlobeNewsWire
- 7 weeks ago - BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 2 months ago - BridgeBio Oncology Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts